While human embryonic stem cells (hESCs) may one day facilitate the treatment of degenerative diseases requiring cell replacement therapy, the success of regenerative medicine is predicated on overcoming the rejection of replacement tissues. Given the role played by dendritic cells (DCs) in the establishment of immunological tolerance, we have proposed that DC, rendered tolerogenic during their differentiation from hESC, might predispose recipients to accept replacement tissues. As a first st...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Rapamycin conditioning of dendritic cells differentiated from human ES cells promotes a tolerogenic phenotype.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record